Medicare Enrolled
Dr. Amar Oza, M.D.
Internal Medicine · Orchard Park, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Oza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oza?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Oza
Dr. Amar Oza is an internal medicine specialist in Orchard Park, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. Oza performed 35,080.8 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Oza received a total of $9,275 from 37 pharmaceutical and/or device companies across 582 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Oza is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 1% volume in NY
$9,275 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗35,080.8
Medicare services
Top 1% in NY for internal medicine
Not available
Unique patients (not deduplicated)
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 10,740 | $18 | $26 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
8,750 | $10 | $23 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
4,975 | $33 | $70 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
4,210 | $62 | $110 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
3,556.8 | $26 | $75 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
367 | $0 | $20 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
333 | $21 | $55 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
325 | $86 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
242 | $11 | $95 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
234 | $96 | $191 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
221 | $4 | $9 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
175 | $48 | $175 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
145 | $6 | $16 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
118 | $28 | $95 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
94 | $1 | $29 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
78 | $28 | $49 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
76 | $9 | $20 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
74 | $127 | $210 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
64 | $12 | $38 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
52 | $26 | $49 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
46 | $50 | $100 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 39 | $13 | $20 |
| Trabecular bone score calculation This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk. |
29 | $31 | $70 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
26 | $32 | $68 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
24 | $99 | $150 |
| New patient office visit, complex (60-74 min) | 24 | $165 | $270 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
23 | $24 | $70 |
| Ultrasound-guided small joint aspiration or injection This procedure involves removing fluid from or injecting medication into a small joint while using ultrasound imaging to guide the needle placement. |
18 | $60 | $110 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
11 | $28 | $74 |
| Limited ultrasound of joint or extremity A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels. |
11 | $33 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
51.5% high complexity
46.6% medium
2.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,275
Total received (2018-2024)
Avg $1,325/year across 7 years
Top 10% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
582
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,032
2023
$1,091
2022
$839
2021
$304
2020
$952
2019
$3,543
2018
$1,515
Payments by company (2024)
ABBVIE INC.
$240
Amgen Inc.
$185
UCB, Inc.
$156
Aurinia Pharma U.S., Inc.
$81
E.R. Squibb & Sons, L.L.C.
$76
Janssen Biotech, Inc.
$72
AstraZeneca Pharmaceuticals LP
$49
Novartis Pharmaceuticals Corporation
$44
Alexion Pharmaceuticals, Inc.
$34
CSL Behring
$33
Daiichi Sankyo Inc.
$23
SOBI, INC
$20
PFIZER INC.
$17
Top 3 companies account for 56.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,336
PFIZER INC.
$1,180
Janssen Biotech, Inc.
$798
UCB, Inc.
$618
Genentech USA, Inc.
$585
ABBVIE INC.
$481
Novartis Pharmaceuticals Corporation
$477
AbbVie, Inc.
$457
E.R. Squibb & Sons, L.L.C.
$424
Celgene Corporation
$376
GlaxoSmithKline, LLC.
$327
Horizon Therapeutics plc
$310
Lilly USA, LLC
$254
AstraZeneca Pharmaceuticals LP
$228
Aurinia Pharma U.S., Inc.
$216
GENZYME CORPORATION
$209
Daiichi Sankyo Inc.
$193
Boehringer Ingelheim Pharmaceuticals, Inc.
$136
AbbVie Inc.
$136
Radius Health, Inc.
$96
Endo Pharmaceuticals Inc.
$47
Octapharma USA, Inc.
$41
Gilead Sciences, Inc.
$38
Grifols USA, LLC
$35
Alexion Pharmaceuticals, Inc.
$34
CSL Behring
$33
Sobi, Inc
$30
Flexion Therapeutics, Inc.
$24
Sandoz Inc.
$24
SOBI, INC
$20
Ironwood Pharmaceuticals, Inc
$18
Ultragenyx Pharmaceutical Inc.
$18
Horizon Pharma plc
$17
Ferring Pharmaceuticals Inc.
$17
Exeltis, USA Inc.
$15
Actelion Pharmaceuticals US, Inc.
$14
Antares Pharma, Inc.
$12
Top 3 companies account for 35.7% of all-time payments
Associated products mentioned in payments ›
AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · Crysvita · DUZALLO · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · Gamunex-C · HUMIRA · HYRIMOZ · Hizentra · Humira · ILARIS · INFLECTRA · INJECTAFER · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · NASCOBAL · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tymlos · UPTRAVI · VIMOVO · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
497
County median income
$71,175
Nearest hospital to ZIP centroid (approximate)
WESTERN NY CHILDRENS PSYCHIATRIC CENTER
5.9 mi
5.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Oza is a mixed practice specialist, with above-average Medicare volume (top 1% in NY).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Oza experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Oza performed 10,740 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Oza receive payments from pharmaceutical companies?
Yes. Dr. Oza received a total of $9,275 from 37 companies across 582 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oza's costs compare to other internal medicine physicians in Orchard Park?
Dr. Oza's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Orchard Park
Browse internal medicine physicians in Orchard Park ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology